Part of the Perforce Continuous Testing Platform, Perfecto AI generates execution-ready test actions from natural language prompts to validate applications across web, Android, and iOS. Seeking to ...

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Senyo Simpson discusses how Rust's core ...

Traditional Medicare will face greater use of prior authorizations under a pilot program by the Centers for Medicare & Medicaid Services, potentially eroding one area that enrollees like about their ...

Self-pay patients may be eligible for some kind of health insurance coverage. Linda Perryclear, Director of Field Services-RCM Client Experience, Availity (Jacksonville, Fla.): Use a tool for ...

July 29 (Reuters) - Guardant Health (GH.O), opens new tab said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the ...

Exact Sciences Corporation (NASDAQ:EXAS) is one of the best mid cap pharma stocks to buy. On July 9, Exact Sciences announced that its Oncodetect molecular residual disease/MRD test received Medicare ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...